EGIS 11004
Alternative Names: S 36550Latest Information Update: 16 Aug 2007
At a glance
- Originator Egis Pharmaceuticals
- Developer Egis Pharmaceuticals; Servier
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders